The present study analyzes if estradiol benzoate and/or progesterone intera
ct with desmethylimipramine (DMI) to diminish experimental anxiety. The ani
mal model of anxiety used was the conditioned defensive burying test. Dose
response curves for DMI (0.625, 1.25 and 2.5 mg/kg, every 24 h, during 21 d
ays), estradiol benzoate (0.5, 1.0, 2.0 and 4.0 mu g/rat, 48 h) and progest
erone (0.5, 1.0 and 2.0 mg/rat, -4 h) were made in ovariectomized rats. DMI
per se decreased dose dependently the cumulative burying time, an effect c
onsidered as anxiolytic-like. Progesterone produced a decrease in burying a
t the highest dose, while estradiol benzoate had no effect on defensive bur
ying. Both: progesterone (0.5 mg/rat) and estradiol benzoate (4.0 mu g/rat)
were able to decrease the cumulative burying behavior when injected with a
subthreshold dose of DMI (1.25 mg/kg). In addition, the effect of DMI (1.2
5 mg/kg) plus the combination of estradiol benzoate and progesterone, seque
ntially administered (48 h and 4 h before the tests, respectively), also pr
oduced a synergistic decrease in burying behavior. In general, the treatmen
ts produced no changes in burying behavior latency, neither in spontaneous
ambulation or in nociception. It is concluded that DMI synergizes its anxio
lytic-like effect when administered with estradiol alone or in combination
with progesterone. Present data provide experimental evidence suggesting an
interaction between hormones and antidepressants. Results are discussed on
the basis of the interaction between steroids and serotonegic or GABAergic
receptors. (C) 2000 Elsevier Science Ltd. All rights reserved.